My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Bristol-Myers Squibb (NY:BMY)

53.47 -0.08 (-0.16%)

Streaming Delayed Price Updated: 1:36 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9

...

84 85 Next >

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

Bristol-Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case ↗

December 02, 2025

Bristol-Myers Squibb (BMY) presents a value investment case, trading at a deep discount with strong earnings power and a high dividend amid near-term challenges.

Via Chartmill

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

December 01, 2025

From Bristol Myers Squibb

Via Business Wire

Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗

November 20, 2025

Via Stocktwits

Topics Workforce

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever ↗

November 30, 2025

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.

Via The Motley Fool

Topics Intellectual Property

2 Top Dividend Stocks to Buy and Hold ↗

November 30, 2025

Patience will be rewarded for those who stick with these two healthcare stocks.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend? ↗

November 29, 2025

The pharma stock yields more than 4x the S&P 500 average.

Via The Motley Fool

Topics Intellectual Property Stocks

Bristol-Myers (BMY) Earnings Call Transcript ↗

November 27, 2025

Bristol-Myers (BMY) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a Compelling Mix of High Yield and Financial Strength for Dividend Investors ↗

November 27, 2025

Bristol-Myers Squibb (BMY) offers a strong 5.4% dividend yield, backed by a history of reliable payments, robust profitability, and a sound financial position for income investors.

Via Chartmill

Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference

November 26, 2025

From Bristol Myers Squibb

Via Business Wire

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma

November 24, 2025

From Bristol Myers Squibb

Via Business Wire

PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Via StockStory

Topics Economy

Monday's session: gap up and gap down stock in the S&P500 index ↗

November 24, 2025

Curious about the S&P500 stocks that are gapping on Monday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Which S&P500 stocks are moving before the opening bell on Monday? ↗

November 24, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

Bristol Myers Squibb to Host Hematology-Focused Investor Event

November 24, 2025

From Bristol Myers Squibb

Via Business Wire

What's Driving the Market Sentiment Around Bristol-Myers Squibb Co? ↗

November 20, 2025

Via Benzinga

Why GRAIL Stock Could Be Biotech’s Next Big Breakout ↗

November 19, 2025

Via MarketBeat

Market Movers in Motion: Merck & Co. and Amer Sports Chart Volatile Courses

November 18, 2025

The financial markets are a constant theater of dynamic shifts, and in recent months, two distinct players – pharmaceutical giant Merck & Co. and global sporting goods powerhouse Amer Sports – have...

Via MarketMinute

Topics Economy Initial Public Offering Intellectual Property

Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers

November 18, 2025

From Bristol Myers Squibb

Via Business Wire

Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q3

November 17, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Bristol-Myers Squibb (NYSE:BMY) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers

November 17, 2025

From Bristol Myers Squibb

Via Business Wire

1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky

November 16, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

These 2 Dividend ETFs Are a Retiree's Best Friend ↗

November 16, 2025

Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.

Via The Motley Fool

Topics Artificial Intelligence Bonds ETFs

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

Stay informed with the top movers within the S&P500 index on Friday. ↗

November 14, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

Discover which S&P500 stocks are making waves on Friday. ↗

November 14, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Tech Rebounds After Selloff, Bitcoin Craters To $97,000: What's Moving Markets Friday? ↗

November 14, 2025

Investors stepped back into beaten-down tech names Friday, with the Nasdaq 100 rising 0.6% by midday in New York, staging a modest rebound after Thursday's sharp selloff.

Via Benzinga

Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy ↗

November 14, 2025

Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026.

Via Benzinga

Friday's session: gap up and gap down stock in the S&P500 index ↗

November 14, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Via Chartmill

Bristol Myers Slumps After Its Heart Condition Study Gets The Boot ↗

November 14, 2025

An independent data monitoring committee said the company's treatment for acute coronary syndrome was likely to fail in testing.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

84 85 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.